Except for paw quality, trace element deficiencies have been clearly identified as a source of the diseases. Providing a trace element source that is recognised to be highly bioavailable in several animal species such as B-TRAXIM 2C would improve animal trace mineral status and reduce the occurrence of deficiencies. The final consequence is the reduction of pathologies, which have been related to trace element deficiency such as tibial dyschondroplasia and perosis. For example, some trace element sources have shown to be more efficient as an enzyme co-factor than others. A numerical increase in alkaline phosphatase levels was observed in rats fed B-TRAXIM 2C Zn compared to ZnSO4.